Cleveland Clinic | 12th Annual Obesity Summit
Avatar

Management of Hypertension and Hyperlipidemia in Type 2 Diabetes

By Cleveland Clinic | 12th Annual Obesity Summit FEATURING Steven Nissen
12/2017
1 Comment
Login to view comments. Click here to Login

Featured Video

15:44
Radius Health

Postmenopausal Osteoporosis in Women at High Risk for Fracture: A Sequen...

Feat. F. Cosman

Related Content

AUTOPLAY
Cardiometabolic Health Congress (CMHC)

14th Annual Cardiometabolic Health Congress (CMHC)

Thu, Oct 10, 2019
Didactic Presentations

Medical, Surgical and Interventional Decision Making in the Prevention a...

Fri, Sep 13, 2019
See 2 others
Didactic Presentations

Cardiovascular Update for the Primary Care Provider

Thu, Oct 24, 2019
Didactic Presentations

24th Pan Arab Conference on Diabetes

Fri, Mar 27, 2020
27:02
ASPC 2019 Congress on CVD Prevention

Expanded use of CAC testing in 2018 Cholesterol Guidelines- How to Apply?

Feat. R. Blankstein
16:56
William White

Ambulatory Blood Pressure Monitoring

20:18
ASPC 2019 Congress on CVD Prevention

The 2018 ACC/AHA Prevention Guidelines - Advancing a Comprehensive Appro...

Feat. R. Blumenthal
18:26
ARCH Advanced Revascularization Symposium

Hypertension 2016: Guidelines and Updates

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

Feat. R. DeFronzo
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty Aci...

Feat. R. Mason
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

18:42
Bonita Falkner

Recent Advances in Pediatric Hypertension

04:42
Cleveland Clinic Heart and Vascular Institute

Heart Outcomes Prevention Evaluation–3 - HOPE-3 Trial

Feat. S. Nissen
13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

07:03
UC Davis Health Diabetes and Endocrinology Symposium

Diabetes and the Kidney

Feat. S. Ananthakrishnan
28:22
Richard Auchus

Primary Aldosteronism and Implications for Primary Hypertension

29:14
Michael Ozner

The Role of Omega-3 Fatty Acids for the Treatment and Prevention of Card...

14:18
Richard Heuser

Immediate Blood Pressure Response: Non-Vascular Treatment for Resistant ...

53:27
Savitha Subramanian

Lipid Lowering: The Story Beyond Statins

12:11
Cardiometabolic Health Congress (CMHC)

Identifying Diabetic Kidney Disease in Patients with T2DM: Causes of and...

22:53
George Bakris

Renal Effects of Diabetes

16:12
ASPC 2018 Congress on CVD Prevention

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Hi...

Feat. P. Moriarty
10:07
Inova Heart and Vascular Institute 2019 Cardiovascular Symposium

The Risk of Living in a Food Desert

Feat. J. Butler
12:19
Bruce Neal

Canagliflozin in Treatment of T2DM and Effects on Renal Disease: Current...